Abstract: The invention provides eTEC linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a (2-((2-oxoethyl)thio)ethyl)carbamate (eTEC) spacer, immunogenic compositions comprising such glycoconjugates, and methods for the preparation and use of such glycoconjugates and immunogenic compositions.

Abstract: Provided herein are compositions and methods for targeted drug delivery to prevent restenosis in the cardiovascular system. In particular, provided herein are nanoscale delivery vehicles for drugs that prevent proliferation and neointimal hyperplasia.

Abstract: The invention relates generally to compositions and methods for conjugating antibodies and activatable antibodies, and methods of partially reducing antibodies and/or activatable antibodies prior to conjugation, e.g., thiol-based conjugation, with an agent, e.g., a therapeutic and/or diagnostic agent.

Abstract: Provides is a therapeutic technology that combines the phototoxic and immune-stimulating ability of photodynamic therapy with the widespread effectiveness of the immune system to reduce the viability of such as cancer cells and tumors. The nanoparticle compositions of the disclosure combine an immunostimulant with a photosensitizer using a nanoparticle delivery platform. For example, zinc pthalocyanine, which is a long-wavelength absorbing photosensitizer, integrated into a polymeric nanoparticle core made up of poly(D,L-lactic-co-glycolic acid)-b-poly(ethylene glycol) (PLGA-b-PEG). The outside surface of the core can be coated with metallic nanoparticles, which are then modified with CpG-ODN. Metastatic mouse breast carcinoma cells showed significant photocytotoxicity of the hybrid after irradiation with a 660 nm LASER light and this activity was remarkably better than either treatment alone.

Abstract: The present invention provides a photoacoustic imaging contrast medium which exhibits a high degree of accumulation into a tumor even when some extent of time has passed after performing administration and which facilitates an increase in the intensity of photoacoustic signal produced by the tumor. A compound produced by covalent-bonding of an organic dye which absorbs light in the near-infrared wavelength region and a PEG having a branch.

Abstract: The invention features 2-alkoxy-11-hydroxyaporphine derivatives that selectively bind D2high receptors. The compounds are useful for imaging D2high receptors and for the treatment of diseases, such as Parkinson's disease, sexual dysfunction, and depressive disorders.

Abstract: Germicidal light fixtures and germicidal light fixture systems. One embodiment of a germicidal light fixture includes a support structure and at least one first lighting device coupled with the support structure operative to emit ultraviolet radiation at a first predetermined wavelength. At least one second lighting device is coupled with the support structure and is operative to emit ultraviolet radiation at a second predetermined wavelength. The first and second predetermined wavelengths are selected such that ultraviolet radiation emitted from the at least one first lighting device and from the at least one second lighting device, respectively, is operative to inactivate microorganisms. At least one third lighting device is coupled with the support structure and is operative to emit visible radiation.

Abstract: A method and irradiator apparatus used for wort sterilization by radiation for production of ethanol from sugar cane, comprising a trough-like fluid duct and a radiation source for directing radiation over the flow of a fluid conducted through the duct, and application of radiation to a fluid within an apparatus for sterilization of such fluid.

Abstract: In a light irradiation apparatus, an elongated body has flexibility that allows for elastic restoration. An LED chip is closely fixed to a tip portion of the elongated body and emits ultraviolet light. A cover unit covers the LED chip so as to protect the LED chip and allows the ultraviolet light emitted by the LED chip to pass through the cover unit. A conductive unit extends in a longitudinal direction of the elongated body and passes electric current for allowing the LED chip to emit light. An insulation unit covers the conductive unit so as to ensure electrical insulation of the conductive unit.

Abstract: A method for multi-agent dry fogging. The method includes pressurizing a first agent to a first range of pressure. The first agent includes a sterilant. The method also includes pressurizing a second agent to a second range of pressure. The second agent includes a non-depleting solution for protection against microorganism growth. The method also includes pressurizing a gas to a gas range of pressure. The method also includes atomizing the first agent at a nozzle to mix with the pressurized gas in a first application stage to disperse the first agent in a first dry fog within an ambient environment. The method also includes atomizing the second agent at the nozzle to mix with the pressurized gas in a second application stage to disperse the second agent in a second dry fog within the ambient environment.

Abstract: Apparatuses are provided which include one or more germicidal sources, power circuitry coupled to the germicidal source/s, and a shield. The shield and/or at least one of the germicidal source/s are moveable within the apparatus and the apparatus is configured such that the shield and/or the germicidal source/s may be brought in and out of proximity with the other and upon doing so germicide projected from one or more of the germicidal source/s is either substantially contained in the apparatus or is projected exterior to the apparatus for different disinfection modes of the apparatus. The apparatuses include a processor and processor-executable program instructions for activating the power circuitry to operate the at least one germicidal source when the germicidal source is not encased within the apparatus and for activating the power circuitry to operate at least one germicidal source when the germicidal source/s are encased within the apparatus.

Abstract: The present invention provides a system and method for treating carpet that includes a hollow tube having a first end and a second end, wherein the tube further includes: a plurality of injection holes located near the second end of the tube, a pointed tip located at the second end of the tube, and a lug moveably attached to the tube; the method including inserting the tube into a carpet by penetrating the pointed tip into the carpet; lifting the tube up via the lug such that a portion of the carpet is pulled away from padding located underneath the carpet; and inserting fluid into the tube at the first end of the tube such that the fluid is injected into the carpet via the injection holes.

Abstract: The present invention relates to an aroma diffusing system and aroma diffusing method thereof. This method includes establishing wireless communication connection between a mobile terminal and an aroma diffuser; receiving user input and generating a corresponding order through the mobile terminal and sending the order in a wireless mode; receiving the order through the wireless communication module of the aroma diffuser and executing the order through the electric control element of the aroma diffuser; feeding back order execution result to the mobile terminal through the wireless communication module of the aroma diffuser; receiving the order execution result through the mobile terminal and giving a corresponding prompt in the mobile terminal. The present invention may control the operation mode of the aroma diffuser and improve operation experience and use experience through a smart phone.

Abstract: The present invention provides a hemostatic composite sponge comprising a porous matrix of a biomaterial and a material enhancing the adherence of said sponge to the applied tissue stably associated with at least one surface of said sponge, a method of producing these sponges and their use in hemostasis.

Abstract: A method of manufacturing an absorbent sanitary paper product having a machine direction, a cross-machine direction orthogonal and co-planar thereto, and a Z-direction orthogonal to both the machine- and cross-machine directions is disclosed. The method comprises the steps of: a. providing a first network of fibers having a first and a second side, each fiber of the first network of fibers having a longitudinal axis generally disposed within the plane comprising the machine- and cross-machine-directions; b. applying a first bonding layer in a first pattern to one of the first and second sides of the first network of fibers; and, c. applying a first second network of fibers to the first bonding layer, the first second network of fibers comprising a combination of a first plurality of fibers and a second plurality of fibers. The first and second pluralities of fibers are different.

Abstract: The present invention provides a water-absorbing agent that includes water-absorbent resin particles as essential components and is suitable for a sanitary material. A water-absorbing agent of the present invention includes water-absorbent resin particles obtained by polymerizing an unsaturated monomer having an acid group. The water-absorbing agent has centrifuge retention capacity (CRC) of 5 to 20 g/g and includes: a compound with a structure unit derived from polyalkyleneglycol other than the unsaturated monomer; and a multivalent metal salt, and accordingly the water-absorbing agent has high saline flow conductivity (SFC) in a range of the above centrifuge retention capacity (CRC).

Abstract: The present invention provides optic portions, intraocular lenses, and polymers for use in manufacturing optic portions and intraocular lenses. The optic portions include a polymer that comprises (a) one or more alkoxyalkyl methacrylate monomers and/or one or more alkoxyalkyl acrylate monomers that are incorporated in the polymer; (b) one or more hydroxyalkyl methacrylate monomers and/or one or more hydroxyalkyl acrylate monomers that are incorporated in the polymer; and (c) optionally, one or more crosslinking agents that are incorporated in the polymer.

Abstract: Implantable biocompatible polymeric medical devices include a substrate with an acid or base-modified surface which is subsequently modified to include click reactive members.

Abstract: A polymer comprising a phosphoryl choline moiety(ies), a composition comprising the polymer and optionally a bioactive agent, an implantable device such as a DES or a non-implantable device such as an angioplasty balloon comprising thereon a coating comprising the polymer and optionally a bioactive agent, and a method of using the device for the treatment of a disorder in a human being are provided.

Abstract: Methods for the synthesis of tricalcium phosphates are presented, as well as a series of specific reaction parameters that can be adjusted to tailor, in specific ways, properties in the tricalcium phosphate precursor precipitate. Particulate tricalcium phosphate compositions having an average crystal size of about 250 nm or less are provided. Compositions of the invention can be used as prosthetic implants and coatings for prosthetic implants.

Abstract: The present invention provides a suction sequence which is considered to produce advantageous results, particularly for mothers with newborn infants. The sequence comprises a process of stimulation, expression, and pausing to closely mimic a newborn's sucking pattern.

Abstract: Dialysis systems are disclosed comprising new fluid flow circuits. Systems may include blood and dialysate flow paths, where the dialysate flow path includes balancing, mixing, and/or directing circuits. Dialysis systems may include a safety system utilizing a field programmable gate array (FPGA) that monitors at least conductivity and temperature of dialysate in the flow circuit upstream of a dialyzer and enters a fail-safe state if the measured conductivity is outside of a range of values. The FPGA may be verified to be operating properly by exposing sensors in fluid paths to temperatures or conductivities that are outside pre-determined permissible ranges of values, and confirming that the FPGA safety system enters a fail-safe state in response to the temperatures or conductivities. The FPGA may be configured to monitor an amount of ultrafiltration fluid withdrawn from a patient during dialysis treatment and to enter a fail-safe state if a maximum amount is exceeded.

Abstract: The specification discloses a portable dialysis machine having a detachable controller unit and base unit. The controller unit includes a door having an interior face, a housing with a panel, where the housing and panel define a recessed region configured to receive the interior face of the door, and a manifold receiver fixedly attached to the panel. The base unit has a planar surface for receiving a container of fluid, a scale integrated with the planar surface, a heater in thermal communication with the planar surface, and a sodium sensor in electromagnetic communication with the planar surface. Embodiments of the disclosed portable dialysis system have improved structural and functional features, including improved modularity, ease of use, and safety features.

Abstract: Apparatus for transdermal or subcutaneous delivery of a bioactive solution, including a plurality of needles fixed on a needle carrier in a spaced apart relationship and projecting from the needle carrier, each needle having a tip zone adapted to receive an amount of bioactive solution from a reservoir coupled to the needle carrier and to deliver the bioactive solution upon penetrating a skin.

Abstract: Packaging is disclosed for a medical needle, such as a pen needle, having a hub with a patient end of the needle protruding from a distal end thereof. The packaging includes a tube having a first closed end into which the patient end of the needle is inserted so that the hub contacts an interior of the tube, a second closed end enclosing a proximal end of the hub, and a circumferential region disposed between the proximal end of the hub and the second closed end for opening the package to expose the proximal end of the hub.

Abstract: A method and apparatus for a connection interface between a reservoir or syringe, infusion set tubing, and an infusion pump is provided. The reservoir, a base and a cap are connected to form an integrated unit that is capable of being inserted and secured in an infusion pump housing. The cap and the infusion pump are each provided with at least one sensor or at least one detectable feature, arranged to interact with at least one corresponding detectable feature or sensor on the other of the cap and infusion pump device, to detect one or more of the presence, position or other characteristic of the cap when the cap is aligned or coupled with the infusion pump housing. The detectable feature and sensor may be magnetic, RF, mechanical, optical or any combination.

Abstract: Some embodiments of an infusion pump system may be configured to provide air pressure equilibrium between the ambient air pressure external to the infusion pump system and the internal air pressure inside the infusion pump system. In particular embodiments, the infusion pump system can be equipped with an air-transmissible, liquid-tight seal along an interface between a pump body and a cap device configured to attach to the pump body.

Abstract: Some embodiments of a medical infusion pump system include a pump device and a removable controller device. When the pump device and the removable controller device are removably attached to one another, the components may provide a portable infusion pump unit to dispense medicine to a user. In particular embodiments, the removable controller device includes a user interface to readily provide information, for example, about the operation of the pump.

Abstract: A method of alerting a user to a potential unintended bolus delivery includes delivering fluid to a patient along a first fluid flow path. The method also includes transmitting a signal prior to initiation of a change in fluid delivery to the patient along a second fluid flow path connected to the first fluid flow path upstream of the patient, and detecting the signal. The method further includes actuating an alarm to alert the user to a potential unintended bolus delivery if the signal is detected. A system for carrying out the method is also provided.

Abstract: Apparatus are provided for infusion devices and related control systems and methods. In one embodiment, an infusion device includes a voided portion adapted to receive a shaft portion that includes a shaft coupled to a plunger of a reservoir. The shaft portion includes a detectable feature, and the infusion device includes a sensing arrangement proximate the voided portion to sense the detectable feature. In some embodiments, a control module is coupled to the sensing arrangement to determine a remaining amount of fluid in the reservoir based at least in part on the sensed position of the detectable feature. In other embodiments, the control module identifies an anomalous condition based at least in part on the sensed position of the detectable feature.

Abstract: A medical device system includes at least one controllable patient-worn or patient-carried medical device, and a plurality of controller devices that are capable of independently controlling features or functions of the patient medical device. Control commands and other data is wirelessly communicated among the patient medical device and the multiple controller devices. A number of techniques, protocols, and other measures are provided to coordinate wireless communication between the various devices in a medical device system. These control command coordination processes address situations where conflicting, redundant, or concurrent control commands might be independently issued by the multiple controller devices.

Abstract: Systems and methods for intelligently delivering fluid to a targeted tissue. The systems and methods may include directing a pump to distribute fluid to a targeted tissue and receiving one or more signals from an intracorporeal sensing system, where the one or more signals correspond to one or more sensed feedback parameters at the targeted tissue. The systems and methods may also include determining whether the one or more sensed feedback parameters are within an acceptable range. If the one or more sensed feedback parameters are not within the acceptable range, the systems and methods may include determining an adjusted velocity for the plunger necessary to adjust the pressure of the fluid in the pump so that the one or more sensed feedback parameters move within the acceptable range and directing the pump to distribute the fluid at the adjusted velocity.

Abstract: A local extremum of a function ƒ is determined by computing a Jacobian of ƒ at a test point x by adding an imaginary part to x and a Hessian of ƒ by adding two imaginary parts to a multicomplex copy of x and extracting a third imaginary part. Solving a system of equations defined by the Jacobian and Hessian yields a delta; the process is repeated until convergence. This method is used in each of a series of time intervals to compute an insulin-delivery amount for an insulin pump. ƒ is a model-predictive-control cost function; x is a set of successive candidate insulin delivery amounts beginning from a selected time interval. A system includes a glucose monitor and a controller using glucose measurement data therefrom to determine an insulin delivery amount for a time interval by minimizing ƒ; an insulin pump provides insulin corresponding to the delivery amount.

Abstract: An apparatus includes a container, a needle, and an actuation assembly. The container contains a dose of a naloxone composition having a delivered volume of at least about 0.34 mL. The actuation assembly includes an energy storage member that produces a force on a movable member to move the needle and to deliver the dose of the naloxone composition. The 90% confidence interval of at least one of the relative mean maximum naloxone plasma concentration after dose delivery into the body (Cmax), time to reach the maximum naloxone plasma concentration (Tmax), area under the plasma concentration-time curve from pre-dose (time 0) extrapolated to infinity (AUC0-?), or area under the plasma concentration-time curve from pre-dose (time 0) to the time of the last quantifiable concentration (Tlast) (AUC0-t) of the delivered dose to a delivered dose of a corresponding naloxone composition delivered via a manually-actuated syringe is within 80% to 125%.

Abstract: A dose setting mechanism comprises a drug delivery device housing and a dual state track provided within the housing that is axially and rotationally fixed with respect to the housing. A dose dial component is positioned in the housing and rotatable during dose setting and dose delivery. A clutch is rotatable during dose setting and non-rotatable during dose delivery. A clutch plate is rotationally fixed relative to the housing; and a clutch blocker is in threaded engagement with the clutch plate and has a radial key engaged with the dual state track. The mechanism may comprise a biasing member positioned between the clutch blocker and clutch plate.

Abstract: An injection device includes a housing, a receptacle for receiving a medicine cartridge and configured for attachment to a proximal end of the housing, and a leadscrew having an end for engaging with a bung of a cartridge. The leadscrew has a first thread extending axially along an outer surface thereof and at least one axially extending guide track. The injection device includes a rotatable drive mechanism for engaging with the first thread or guide track, and a guiding element for engaging with the other of the first thread or guide track, the guiding element being non-rotatable with respect to the housing during an injection operation, whereby rotation of the drive mechanism causes the leadscrew to move axially in a proximal direction in order to deliver a dose from the cartridge. The injection device further includes a stop member located proximal to the rotatable drive mechanism and the guiding element.

Abstract: A resettable dose setting mechanism for a drug delivery device comprising a driver for driving a spindle of the drug delivery device is provided. Said driver comprises a first component and a second component rotationally coupled to said first component. During resetting of said drug delivery device, said first component is rotationally decoupled from said second component.

Abstract: A drive mechanism for a drug delivery device having a rotationally fixed plunger rod driven by a lead screw. The lead screw engages a free lock which is coupled to a release knob. A dose setting dial cooperates with an inner cylinder using a clutch to establish the axial movement of the plunger rod during dose setting and dispensing.

Abstract: The present invention relates to a cap assembly for a drug delivery device, comprising: a cap body (12) adapted to releasably engage with a housing of the drug delivery device and being further adapted to receive a needle assembly to be releasably interconnected with said housing, an ejector unit movably arranged on the cap body at least along the body's long axis and having mechanical transmission means adapted to transfer axial movement of the ejector unit to the needle assembly for ejecting the needle assembly from the cap body.

Abstract: A dose indicator device for a pressurized metered dose inhaler comprises an inner wheel, annular outer wheel, actuator and housing; the inner wheel comprising primary indexing teeth and a flexible drive arm; the outer wheel comprising secondary indexing teeth on an outer face of the outer wheel; the inner wheel and outer wheel located at least partially within the housing such that the inner wheel and outer wheel are rotatable about a common longitudinal axis of rotation; the actuator movable in a plane perpendicular to the axis of rotation to engage the primary indexing teeth to rotate the inner wheel; the housing being fixed relative to the axis of rotation and comprising a deflector; the deflector configured such that, on rotation of the inner wheel, the drive arm is intermittently deflected and brought into contact with the secondary indexing teeth to rotate the outer wheel about the axis of rotation.

Abstract: A respiratory treatment device comprising at least one chamber, a chamber inlet configured to receive air into the at least one chamber, at least one chamber outlet configured to permit air to exit the at least one chamber, and a flow path defined between the chamber inlet and the at least one chamber outlet. A restrictor member positioned in the flow path is moveable between a closed position, where a flow of air along the flow path is restricted, and an open position, where the flow of air along the flow path is less restricted. A vane in fluid communication with the flow path is operatively connected to the restrictor member and is configured to reciprocate between a first position and a second position in response to the flow of air along the flow path.

Abstract: A flexible transparent multiple use face mask that encloses a user's face allowing the user's airway to be ventilated that includes a transparent flexible airway mask that encloses and ventilates a user's airway, an airway adaptor that directs a quantity of ventilation to the transparent flexible airway mask, a manual resuscitation bag valve that receives the airway adaptor and controls the quantity of ventilation directed to the transparent flexible airway mask and a manual resuscitation bag that produces the quantity of ventilation transmitted through the airway adaptor to the transparent flexible airway mask. The multiple-use airway mask can also be turned inside out and be used in combination with an endotracheal tube or a tracheotomy tube and also includes an attachment strap to prevent losing the transparent flexible airway mask as an added safety measure to keep the mask and bag connected.

Abstract: Headgear for use with a respiratory mask is described. The headgear comprises a continuous and substantially curved elongate member extending in use below a user's nose and at least two headgear straps capable of attachment to the ends of the elongate member. A mask attachment on the elongate member is disposed to sit below or on one of said user's nose, mouth, upper lip and an inlet to the mask. The attachment is capable of receiving the mask.

Abstract: The invention concerns a nasal cannula assembly (10) adapted to deliver gases to a patient comprising a first compartment (1) and a second compartment (2) separated by a separation wall (6); a pair of nasal prongs (5) in fluid communication with the first compartment (1); the first compartment (1) comprising a first inlet (11) for introducing a first gas into said first compartment (1); the second compartment (2) comprising a second inlet (2) for introducing a second gas into said second compartment (2); and the separation wall (6) comprising at least one flow restriction element (35) for controlling the passage of gas from the second compartment (2) to the first compartment (1).

Abstract: For reducing a discomfort feeling brought by wearing a breathing mask, a wearing tool for the breathing mask which covers nostrils of a user and supplies gas for breathing to the nostrils comprises a pair of connecting members each of which has a longitudinal shape and has a first end portion which is connected to the breathing mask, and a pair of fixing members each of which is connected to a second end portion of the fixing member and is plugged in the tragus of the user. Hence a discomfort feeling due to restraining around the head of the user can be reduced.

Abstract: A patient interface for delivering breathable gas to a patient includes a mask having a sealing portion adapted to form a seal with the patient headgear adapted to secure the mask to a head of the patient and an adjustable strap assembly including a pair of straps connected to one another in a length adjustable manner.

Abstract: A tube for a ventilation system (1) for newborns is provided with a first section (7) comprising a heating wire (14), an electrical conductor (15), and a first connector (9) and a second connector (10), and with a second section (8) comprising a heating wire (16) extending over at least a certain portion of its length, an electrical line (17) extending over at least a certain portion of its length, and a first connector (11) and a second connector (12), wherein the second section (8) comprises a temperature sensor (18), wherein the electrical and pneumatic connection of the first section (7) with the second section (8) via the connection of the second connector (10) of the first section (7) is achievable by either connecting to the first connector (11) of the second section (8), so that the second section (8) is substantially heatable, or by connecting to the second connector (12) of the second section (8), so that the second section (8) is substantially not heatable.

Abstract: A flowmeter comprises a lower valve body (1), a throttle assembly, a flow tube assembly, an upper valve body (2), and a pressure fluctuation suppression assembly. An air inlet, an air outlet and an air flow channel connecting the air inlet and the air outlet are arranged in the lower valve body (1); a throttle assembly for adjusting the degree of opening of the air flow channel in the lower valve body (1) is further disposed on the lower valve body (1).

Abstract: An improved splittable medical device introducer designed to introduce a medical device such as a lead or catheter, into a patient's vasculature without loss of blood or introduction of air is described. The introducer assembly is designed with a notch provided at the proximal end of the introducer housing. The notch, which may comprise a multitude of cross-sectional geometries, is designed to reduce the force required to separate the housing and the introducer sheath, thereby minimizing the possibility of unintentional dislodgement during separation. The notch also increases the repeatability and consistency of the amount of force required to separate the introducer housing and sheath.

Abstract: An intravenous catheter has a tip portion, an extendable portion and a proximal portion attached to a hub. The extendable portion has a refracted position and an extended position. A wire may be incorporated in the intravenous portion. The wire may have a receiver disposed in the tip portion. An extender tool is insertable and removable from the catheter. The extender is dimensioned to engage the receiver upon insertion into said catheter and lengthen the extendable portion of said catheter to said extended position when inserted.